Items where authors include "Seidman, AD"

Export as [feed] Atom [feed] RSS
Number of items: 4.

Article

Tripathy, D, Tolaney, SM, Seidman, AD et al. (9 more authors) (2019) ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases. Future Oncology, 15 (19). pp. 2211-2225. ISSN 1479-6694

Proceedings Paper

Tripathy, D, Tolaney, SM, Seidman, AD et al. (9 more authors) (2018) ATTAIN: Phase III study of etirinotecan pegol (EP) vs treatment of physician's choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (BM) previously treated with an anthracycline, a taxane, and capecitabine (ATC). In: Annals of Oncology. 43rd ESMO Congress (ESMO 2018), 19-23 Oct 2018, Munich, Germany. Oxford University Press .

Tripathy, D, Sara, T, Seidman, AD et al. (9 more authors) (2018) ATTAIN: Phase 3 study of etirinotecan pegol (EP) vs treatment of physician's choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (BM) previously treated with an anthracycline, a taxane, and capecitabine (ATC). In: Cancer Research. 2017 San Antonio Breast Cancer Symposium, 05-09 Dec 2017, San Antonio, Texas, U.S.A.. American Association for Cancer Research .

Tripathy, D, Tolaney, S, Seidman, AD et al. (5 more authors) (2017) Phase 3 study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer who have stable brain metastases previously treated with an anthracycline, a taxane, and capecitabine. In: Cancer Research. 2016 San Antonio Breast Cancer Symposium, 06 Dec 2016 - 10 Dec 2010, San Antonio, Texas, U.S.A.. American Association for Cancer Research .

This list was generated on Sun Mar 24 17:59:11 2024 GMT.